Pulmonary Segmentectomy for Lung Cancer: A Real-World International Registry-TSOG 108
Status: Recruiting
Location: See all (10) locations...
Intervention Type: Other
Study Type: Observational
SUMMARY
Participants will complete questionnaires before surgery, between 2 to 4 weeks after surgery, and 6 months after surgery.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Age ≥18 years
• Clinical Stage I with suspected NSCLC, classified preoperatively based on the AJCC TNM staging manual, 9th edition o Note: Tissue diagnosis of NSCLC is not required before enrollment. A pathologic diagnosis of NSCLC may be confirmed preoperatively with biopsy, intraoperatively with frozen section, or postoperatively on final pathology
Locations
United States
Illinois
Rush University Medical Center (Data collection only)
RECRUITING
Chicago
Michigan
University of Michigan (Data Collection Only)
RECRUITING
Ann Arbor
New Jersey
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
RECRUITING
Basking Ridge
Memorial Sloan Kettering Monmouth (Limited Protocol Activities)
RECRUITING
Middletown
Memorial Sloan Kettering Bergen (Limited Protocol Activities)
RECRUITING
Montvale
New York
Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities)
RECRUITING
Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities)
RECRUITING
Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
RECRUITING
New York
Memorial Sloan Kettering Nassau (Limited Protocol Activities)
RECRUITING
Uniondale
Other Locations
Canada
University Health Network (Data Collection Only)
RECRUITING
Toronto
Contact Information
Primary
David Jones, MD
jonesd2@mskcc.org
212-639-6428
Backup
Bernard Park, MD
parkb@mskcc.org
646-888-3346
Time Frame
Start Date: 2024-05-15
Estimated Completion Date: 2029-05-15
Participants
Target number of participants: 600
Treatments
Participants with Lung Cancer
Participants undergoing planned pulmonary segmentectomy for primary lung cancer
Related Therapeutic Areas
Sponsors
Leads: Memorial Sloan Kettering Cancer Center